Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Running, not enrolling · Phase 3
Conditions studied: Non-Small Cell Lung Cancer
In brief
The goal of this clinical study is to compare the study drug, sacituzumab govitecan-hziy (SG), versus docetaxel in participants with advanced or metastatic (cancer that has spread) non-small cell lung cancer (NSCLC).
Key facts
- Study ID
- NCT05089734
- Run by
- Gilead Sciences
- People needed
- 603
- Starts
- 2021-11-17
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-05-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USOR - Arizona Oncology Associates Tucson - Wilmot — Tucson, Arizona, United States
- Beverly Hills Cancer Center — Beverly Hills, California, United States
- Rocky Mountain Cancer Centers - Aurora — Aurora, Colorado, United States
- Florida Cancer Specialists (Administration and Drug Shipment) — Fort Myers, Florida, United States
- Woodlands Medical Specialists, PA — Pensacola, Florida, United States
- Florida Cancer Specialists — St. Petersburg, Florida, United States
- Florida Cancer Specialists — West Palm Beach, Florida, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Illinois Cancer Specialists — Niles, Illinois, United States
- Siouxland Regional Cancer Center dba June E. Nylen Cancer Center — Sioux City, Iowa, United States
- Kansas City VA Medical Center — Westwood, Kansas, United States
- Baptist Health Lexington — Lexington, Kentucky, United States
- Maryland Oncology Hematology, P.A. — Clinton, Maryland, United States
- Lahey Hospital & Medical Center — Burlington, Massachusetts, United States
- Park Nicollet Frauenshuh Cancer Center — Saint Paul, Minnesota, United States
- Nebraska Hematology - Oncology — Lincoln, Nebraska, United States
- Comprehensive Cancer Centers of Nevada — Henderson, Nevada, United States
- Broome Oncology, LLC — Johnson City, New York, United States
- Stony Brook Cancer Center — Stony Brook, New York, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina, United States
- W.G (Bill) Hefner VAMC — Salisbury, North Carolina, United States
- Zangmeister Cancer Center — Columbus, Ohio, United States
- Tennessee Oncology, PLLC — Chattanooga, Tennessee, United States
- Alaska Oncology and Hematology, LLC. — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.